Roche investing $50B in U.S. facilities, including gene therapy manufacturing in Pennsylvania
Switzerland-based Roche, a branded medicines manufacturer, plans to invest $50 billion in its U.S. facilities over the next five years, including constructing a gene therapy manufacturing facility in ...
Read More